PRODUCTS SOLD ON PEPTIDESLABUAE.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
PRODUCTS SOLD ON PEPTIDESLABUAE.COM ARE FOR RESEARCH PURPOSES ONLY AND ARE NOT FOR HUMAN OR VETERINARY USE.
£59.00
Buy GLP-1 Peptide in UAE – In Stock & Ready to Ship
GLP-1 (Glucagon-Like Peptide-1) is a widely researched peptide known for its role in metabolic regulation and insulin secretion studies. Each batch is independently verified at ≥99% purity and comes with a full Certificate of Analysis (COA) and HPLC testing documentation — giving UAE research teams the confidence they need when sourcing peptides for serious work.
For research use only. Not intended for human or veterinary use.
GLP-1 (Glucagon-Like Peptide-1) is a naturally occurring incretin hormone studied extensively in metabolic and endocrinology research for its central role in insulin secretion, glucose homeostasis, appetite regulation, and pancreatic function — making it one of the most important and widely researched peptides in the global field of metabolic science. Researchers and institutions across the UAE, Dubai, Abu Dhabi and the wider GCC can source verified, research-grade GLP-1 with fast international dispatch and full batch documentation included.
✅ ≥99% Purity — HPLC & Mass Spectrometry Verified
✅ Batch-Specific Certificate of Analysis (CoA) Included
✅ Sterile Lyophilised Powder | GMP Manufactured
✅ Fast International Dispatch to UAE & GCC
GLP-1 is a 30-amino acid incretin peptide produced and secreted by L-cells in the small intestine in response to food intake. It is derived from the proglucagon gene — the same gene that produces glucagon — and acts as a key hormonal signal that coordinates the body’s metabolic response to nutrient ingestion. Upon release, GLP-1 travels via the bloodstream to target tissues including the pancreas, brain, stomach, and heart, where it exerts its biological effects through the GLP-1 receptor (GLP-1R).
Native GLP-1 has a very short half-life in biological systems — typically less than two minutes — due to rapid degradation by the enzyme DPP-4 (dipeptidyl peptidase-4). This makes native GLP-1 a particularly useful research tool for studying receptor pharmacology and acute incretin signalling, while longer-acting synthetic analogues like Semaglutide are used for sustained GLP-1R activation studies. The GLP-1 receptor system has become one of the most actively researched pathways in metabolic science globally, with research institutions across the UAE and GCC contributing to this expanding field alongside growing regional interest in diabetes and metabolic health research.
In controlled laboratory and pre-clinical research settings, GLP-1 has been studied across an extensive range of metabolic, endocrinological, and physiological research applications:
Insulin Secretion Research: GLP-1’s most studied function is its glucose-dependent stimulation of insulin secretion from pancreatic beta cells. Studies use native GLP-1 to examine GLP-1R-mediated insulin release mechanisms, beta cell signalling pathways, and how incretin-driven insulin secretion differs from glucose-stimulated secretion alone.
Pancreatic Beta Cell Biology: Research has examined GLP-1’s influence on beta cell survival, proliferation, and function in cellular models — including studies exploring how GLP-1R activation affects beta cell mass and response to metabolic stress.
Glucose Homeostasis Studies: Studies have investigated GLP-1’s role in coordinating postprandial glucose regulation — including its effects on insulin secretion, glucagon suppression, and gastric emptying — to understand how the incretin system maintains blood glucose balance after meals.
Glucagon Suppression Research: GLP-1 suppresses glucagon secretion from pancreatic alpha cells in a glucose-dependent manner. Research has examined this mechanism as a key component of how GLP-1 regulates overall glucose balance, complementing its insulin-stimulating effects.
Appetite and Satiety Signalling: Studies have explored GLP-1’s influence on appetite-regulating centres in the hypothalamus and brainstem, examining how peripheral GLP-1 release signals satiety to the central nervous system and influences food intake behaviour in pre-clinical models.
Cardiovascular Research: GLP-1 receptors are expressed in cardiac tissue, and research has examined GLP-1’s influence on heart rate, cardiac function, and vascular biology — reflecting growing interest in the cardiovascular dimensions of incretin biology.
GLP-1 Receptor Pharmacology: Native GLP-1 is used as a reference ligand in GLP-1R binding assays, helping researchers characterise synthetic analogues, receptor agonists, and antagonists relative to the endogenous ligand’s pharmacological profile.
DPP-4 Enzyme Research: GLP-1’s rapid degradation by DPP-4 makes it a useful tool for studying DPP-4 enzyme kinetics, inhibitor pharmacology, and how DPP-4 inhibition affects incretin bioavailability in pre-clinical metabolic models.
Neuroprotection Studies: GLP-1 receptors are expressed in the brain, and research has examined GLP-1’s influence on neuronal survival, neuroinflammation, and neuroprotective signalling — reflecting growing interest in the neuroscience dimensions of incretin biology.
All applications listed are research-based only. GLP-1 as supplied is not approved for human therapeutic use.
GLP-1 has one of the most extensive and impactful research profiles of any metabolic peptide in modern science:
Decades of incretin biology research have firmly established GLP-1’s role as a primary coordinator of postprandial metabolic responses, with studies consistently documenting its glucose-dependent insulin secretion mechanism, glucagon suppression activity, and gastric motility effects in both cellular and animal models. Pancreatic research has produced a substantial body of work examining GLP-1’s trophic effects on beta cells — with studies reporting influences on beta cell proliferation, apoptosis resistance, and insulin gene expression in cellular models — generating sustained interest in GLP-1R signalling as a target for metabolic disease research. Appetite research has documented GLP-1’s central nervous system effects in pre-clinical models, with studies examining how peripheral and central GLP-1 signalling interact to regulate food intake — contributing foundational knowledge to the development of GLP-1R agonist research tools. Cardiovascular research has reported cardioprotective properties of GLP-1 in pre-clinical ischaemia models, with studies examining heart rate effects, myocardial function parameters, and vascular biology outcomes under GLP-1R stimulation. Neurological research has examined GLP-1R signalling in models of neurodegeneration and neuroinflammation, with studies exploring how incretin pathway activation influences neuronal survival and inflammatory markers in brain tissue models. The entire class of GLP-1 receptor agonist research compounds — including Semaglutide, Liraglutide, and Tirzepatide — is built upon the foundational pharmacology established through native GLP-1 research, making it one of the most consequential peptides in modern metabolic science.
| Feature | Native GLP-1 | Semaglutide | Liraglutide | Tirzepatide |
|---|---|---|---|---|
| Type | Endogenous incretin | Synthetic GLP-1 analogue | Synthetic GLP-1 analogue | GLP-1/GIP dual agonist |
| Half-Life | ~2 minutes | ~7 days | ~13 hours | ~5 days |
| DPP-4 Resistance | No | Yes | Yes | Yes |
| Research Use | Reference ligand / acute studies | Sustained GLP-1R studies | Sustained GLP-1R studies | Dual receptor studies |
| Receptor Selectivity | GLP-1R only | GLP-1R only | GLP-1R only | GLP-1R + GIPR |
| Best For | Receptor pharmacology / acute signalling | Long-duration metabolic studies | Intermediate duration studies | Multi-receptor research |
| Parameter | Specification |
|---|---|
| Full Name | Glucagon-Like Peptide-1 (GLP-1) |
| Length | 30 Amino Acids |
| Origin | Incretin hormone — proglucagon derived |
| Receptor Target | GLP-1R (GLP-1 Receptor) |
| Purity | ≥99% (HPLC & MS Verified) |
| Form | Sterile Lyophilised Powder |
| Solubility | Sterile water, bacteriostatic water, PBS |
| Storage (powder) | -20°C, protect from light |
| Storage (reconstituted) | 2–8°C, use promptly |
Every order of GLP-1 dispatched to the UAE and GCC includes:
Can I buy research-grade GLP-1 in the UAE?
Yes. We supply research-grade GLP-1 (Glucagon-Like Peptide-1) with international dispatch to the UAE, Dubai, Abu Dhabi, Sharjah and across the GCC. All orders include full batch documentation and are packaged to maintain peptide integrity throughout transit. This compound is supplied strictly for laboratory research use only.
What is the difference between native GLP-1 and Semaglutide?
Native GLP-1 is the endogenous incretin hormone produced naturally in the intestine. It has a very short half-life of approximately two minutes due to rapid DPP-4 enzyme degradation, making it ideal for acute receptor pharmacology studies and short-duration signalling research. Semaglutide is a synthetic GLP-1 analogue engineered to resist DPP-4 degradation and has a half-life of approximately seven days — making it suited to sustained GLP-1R activation studies. Native GLP-1 is used as the reference ligand against which all synthetic analogues are characterised in receptor binding research.
Why does GLP-1 have such a short half-life?
GLP-1 is rapidly cleaved and inactivated by DPP-4 (dipeptidyl peptidase-4), an enzyme present in plasma and on the surface of endothelial cells throughout the body. This short half-life is a feature of the endogenous hormone’s design — GLP-1 acts as a rapid postprandial signal rather than a sustained circulating hormone. In research settings, this rapid degradation makes native GLP-1 useful for acute signalling studies, while DPP-4 resistant analogues are used when sustained receptor activation is required.
What is the incretin effect and why is it important in metabolic research?
The incretin effect refers to the observation that orally ingested glucose produces a significantly greater insulin secretory response than the same amount of glucose administered intravenously — demonstrating that gut-derived hormones like GLP-1 substantially amplify pancreatic insulin release beyond what blood glucose alone can trigger. This incretin effect accounts for a significant proportion of postprandial insulin secretion and is a central concept in metabolic disease research, making GLP-1 a foundational compound for laboratories studying glucose regulation and pancreatic function.
What purity is required for GLP-1 receptor research?
A minimum of ≥98% is considered research grade, though ≥99% is strongly preferred for sensitive receptor binding assays, insulin secretion studies, and incretin signalling experiments where compound purity directly affects pharmacological accuracy. All our GLP-1 is independently verified to ≥99% purity.
How is GLP-1 reconstituted for laboratory use?
Allow the vial to reach room temperature before opening. Add sterile water, bacteriostatic water, or PBS slowly down the vial wall and swirl gently without shaking. Given GLP-1’s sensitivity to degradation, use promptly after reconstitution or aliquot immediately and store at -80°C to preserve activity across multiple experimental uses.
How quickly is GLP-1 delivered to UAE?
Orders are dispatched promptly via tracked international courier. Delivery to the UAE typically takes 3–5 working days, with packaging designed to maintain peptide stability throughout transit.
Research Disclaimer: GLP-1 (Glucagon-Like Peptide-1) is supplied exclusively for legitimate scientific research purposes conducted within licensed laboratory environments. This product is not intended for human consumption, self-administration, or any therapeutic application. It must be handled by qualified researchers in compliance with applicable UAE regulations and institutional ethics guidelines. Handling should only be performed by qualified laboratory professionals in controlled research settings with appropriate institutional authorisations in place. By purchasing, you confirm that this compound will be used solely for approved in-vitro or pre-clinical research purposes.
Receive News
